Literature DB >> 1379039

Complementary DNA sequence of human amyloidogenic immunoglobulin light-chain precursors.

P Aucouturier1, A A Khamlichi, J L Preud'homme, M Bauwens, G Touchard, M Cogné.   

Abstract

The primary structure of three amyloid precursor light chains was deduced from the sequence of complementary DNA (cDNA) from bone marrow cells from patients affected with classical lambda (patient Air) or kappa (patient Arn) amyloidosis and from a patient (Aub) in whom lambda amyloid deposits were unusual by their perimembranous location in the kidney glomerulus. All three RNAs were of normal size, as estimated by Northern blotting, and encoded normal-sized light chains. The deduced light-chain sequence from patient Arn was related to the V kappa 1 subgroup, and included ten residues that had not been previously reported at these positions, only one of which (Leu-21) was located in a beta-sheet (4-2). The unusual presence of Asn-70 determined a potential N-glycosylation site. The sequence of the light chain from patient Air belonged to the V lambda 1 subgroup, and included three unusually located amino acid residues, one of which had already been reported in an amyloidogenic lambda-chain. The sequence of the light chain from patient Aub was related to the V lambda 3 subgroup, and contained five amino acid residues that had not previously been described at the corresponding positions; two of them (His-36 and Ser-77) were located in beta-sheets (3-1 and 4-3 respectively). This sequence was also peculiar because of the presence of numerous acidic residues in the complementarity-determining regions. Such unusual primary structures might be responsible for the amyloidogenic properties of these light-chain precursors.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1379039      PMCID: PMC1132758          DOI: 10.1042/bj2850149

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  27 in total

1.  Aberrant immunoglobulin synthesis in light chain amyloidosis. Free light chain and light chain fragment production by human bone marrow cells in short-term tissue culture.

Authors:  J Buxbaum
Journal:  J Clin Invest       Date:  1986-09       Impact factor: 14.808

2.  Relevance of class, molecular weight and isoelectric point in predicting human light chain amyloidogenicity.

Authors:  V Bellotti; G Merlini; E Bucciarelli; V Perfetti; S Quaglini; E Ascari
Journal:  Br J Haematol       Date:  1990-01       Impact factor: 6.998

3.  Immunogenic and antigenic epitopes of Ig. XXV. Monoclonal antibodies that differentiate the Mcg+/Mcg- and Oz+/Oz- C region isotypes of human lambda L chains.

Authors:  M R Walker; A Solomon; D T Weiss; H F Deutsch; R Jefferis
Journal:  J Immunol       Date:  1988-03-01       Impact factor: 5.422

4.  Prognostic value of urinary protein in primary systemic amyloidosis (AL).

Authors:  M A Gertz; R A Kyle
Journal:  Am J Clin Pathol       Date:  1990-09       Impact factor: 2.493

5.  The amino-acid sequence of the variable region of a carbohydrate-containing amyloid fibril protein EPS (immunoglobulin light chain, type lambda).

Authors:  K G Toft; K Sletten; G Husby
Journal:  Biol Chem Hoppe Seyler       Date:  1985-07

6.  Primary structure of the variable region of an amyloidogenic Bence Jones protein NIG-77.

Authors:  H Tonoike; F Kametani; A Hoshi; T Shinoda; T Isobe
Journal:  Biochem Biophys Res Commun       Date:  1985-02-15       Impact factor: 3.575

7.  Molecular cloning of a human immunoglobulin lambda chain variable sequence.

Authors:  Y Tsujimoto; C M Croce
Journal:  Nucleic Acids Res       Date:  1984-11-26       Impact factor: 16.971

8.  The complete amino acid sequence of a prototype immunoglobulin-lambda light-chain-type amyloid-fibril protein AR.

Authors:  K Sletten; J B Natvig; G Husby; J Juul
Journal:  Biochem J       Date:  1981-06-01       Impact factor: 3.857

Review 9.  Primary systemic amyloidosis--a diagnostic primer.

Authors:  M A Gertz; R A Kyle
Journal:  Mayo Clin Proc       Date:  1989-12       Impact factor: 7.616

10.  Immunoglobulin synthesis in primary and myeloma amyloidosis.

Authors:  J L Preud'homme; D Ganeval; J P Grünfeld; L Striker; J C Brouet
Journal:  Clin Exp Immunol       Date:  1988-09       Impact factor: 4.330

View more
  6 in total

1.  Structural relationship of kappa-type light chains with AL amyloidosis: multiple deletions found in a VkappaIV protein.

Authors:  M A Alim; S Yamaki; M S Hossain; K Takeda; M Kozima; T Izumi; I Takashi; T Shinoda
Journal:  Clin Exp Immunol       Date:  1999-12       Impact factor: 4.330

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1992-10-11       Impact factor: 16.971

3.  Primary structure of a variable region of the V kappa I subgroup (ISE) in light chain deposition disease.

Authors:  A Rocca; A A Khamlichi; P Aucouturier; L H Noël; L Denoroy; J L Preud'homme; M Cogné
Journal:  Clin Exp Immunol       Date:  1993-03       Impact factor: 4.330

4.  Recombinant immunoglobulin variable domains generated from synthetic genes provide a system for in vitro characterization of light-chain amyloid proteins.

Authors:  P W Stevens; R Raffen; D K Hanson; Y L Deng; M Berrios-Hammond; F A Westholm; C Murphy; M Eulitz; R Wetzel; A Solomon
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

5.  Complete primary sequences of two lambda immunoglobulin light chains in myelomas with nonamyloid (Randall-type) light chain deposition disease.

Authors:  C Decourt; G Touchard; J L Preud'homme; R Vidal; H Beaufils; M C Diemert; M Cogné
Journal:  Am J Pathol       Date:  1998-07       Impact factor: 4.307

6.  Production of functional soluble Dectin-1 glycoprotein using an IRES-linked destabilized-dihydrofolate reductase expression vector.

Authors:  Say Kong Ng; Tessa Rui Min Tan; Yang Wang; Daniel Ng; Lin-Tang Goh; Muriel Bardor; Victor Vai Tak Wong; Kong Peng Lam
Journal:  PLoS One       Date:  2012-12-26       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.